Cord Blood Stem Cells Successfully Expanded in Phase 1 of Harvard Stem Cell Institute Study

In HCSI's human clinical trial , scientists provided stem cell transplants to 12 patients using cord blood stem cells that had been treated with a molecule known as 16-dimethyl prostaglandin E2 .

http://www.biospace.com/news_story.aspx?StoryID=314701&full=1